French biotech Cellectis takes stake in Mayflower-backed startup PrimeraBusiness, R&D, TherapeuticsFrench biotech Cellectis said on Thursday it will take a 19% stake in the gene-editing technology startup Primera Therapeutics, launched by the private firm Mayflower Bioventures. Read more December 29, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/12/Cellectislogo.jpg 415 1044 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-12-29 19:14:182022-12-30 10:44:12French biotech Cellectis takes stake in Mayflower-backed startup Primera
